MedTrace Logo

Omega-3 Supplementation in HIV Patients With Therapeutic Lifestyle Change Diet.

NCT02537236 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2015-09-02

No results posted yet for this study

Summary

The positive patients to the Human Immunodeficiency Virus (HIV) with Highly Active Antiretroviral Therapy (HAART) present multiple alterations in their corporal composition and dyslipidemia, wich increase the cardiovascular risk.

The investigators evaluated the efficiency of the combination of fish oil omega 3 fatty acids to different doses with the Therapeutic Lifestyle Changes (TLC) diet of the National Cholesterol Education Program on the profile of lipids and the corporal weight in patients with HIV treated with HAART.

Conditions

  • Human Immunodeficiency Virus

Interventions

DIETARY_SUPPLEMENT

Omega-3 fatty acids

Omega-3 fatty acid supplementation with fish oil.

BEHAVIORAL

TLC nutritional intervention

nutritional orientation.

DIETARY_SUPPLEMENT

Omega-3 fatty acid supplementation with fish oil and TLC nutritional intervention.

Omega 3 fatty acid supplementation with fish oil and nutritional counseling of TLC diet.

Sponsors & Collaborators

  • Hospital Civil de Guadalajara

    collaborator OTHER

  • Instituto Mexicano del Seguro Social

    lead OTHER_GOV

Principal Investigators

  • Alejandro González-Ojeda, MD. PhD. F.A.C.S. · Instituto Mexicano del Seguro Social

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2009-05-31
Completion
2009-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02537236 on ClinicalTrials.gov